140
Participants
Start Date
June 28, 2018
Primary Completion Date
December 20, 2019
Study Completion Date
December 20, 2019
Clobetasol Propionate
Rivelin® patch is a two-layer patch comprised of a muco-adhesive, drug-delivery layer and a protective layer.
Rigshospitalet, Copenhagen
University of Copenhagen Department of Odontology, Copenhagen
NYU College of Dentistry, Bluestone Center for Clinical Research, New York
University of Pennsylvania Health System, Dept. Oral amd Maxillofacial Surgery, Philadelphia
UNC Dermatology and Skin Cancer Center, Chapel Hill
Carolinas Center for Oral Health, Charlotte
The Dental College of Georgia, Augusta
QWay Research, Hialeah
Vitae Research Center, LLC, Miami
Valencia Medical & Research Center, Miami
ENT Associates of Texas, Frisco
Texas A&M University (TAMU), College of Dentistry, Dallas
LMU München, Klinik und Poliklinik für Dermatologie und Allergologie, Munich
The Oral and Facial Surgery Center, Clearfield
Tufts University, School of Dental Medicine, Boston
Brigham and Women's Hospital, Division of Oral Medicine and Dentistry, Boston
UT Southwestern Medical Center Department of Surgery, Dallas
Kaye Edmonton Clinic, Edmonton
Health Sciences North, North East Cancer Center, Greater Sudbury
Cork University Dental School and Hospital, Cork
School of Dental Sciences Newcastel Upon Tyne, Newcastle upon Tyne
Edinburgh Dental Institute, Edinburgh
University of Glasgow Dental School, Glasgow
Leeds Dental Institute, Leeds
King´s College London Dental Institute, Oral Clinical Research Unit, London
University College London and University College London Hospitals Trust, London
University of Sheffield, School of Clinical Dentistry, Sheffield
Lead Sponsor
Proinnovera GmbH
INDUSTRY
X-act Cologne Clinical Research GmbH
INDUSTRY
Dermtreat
INDUSTRY